Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients


Much has changed in the four years since COVID-19 was first identified. This includes the virus itself, the recommendations for preventing infection, treatments, reporting, and disease outcomes. While most people have gone about their daily lives not worrying about repeat COVID-19 infections, those who have compromised immune systems still need to be cautious and vigilant with infection control measures and continue to consider the risk.

Join CLL Society and Dr. Shahzad Mustafa as they discuss the status of COVID-19 in the US and what it means for those who are immunocompromised. Additionally, prevention and post-infection isolation recommendations, strategies that can be used to help individuals to safely interact with their community, and an update on the status of pre-exposure prevention using monoclonal antibodies will be discussed.


Speaker and Moderator:
RB Headshot 2_Color_July 2023

Robyn Brumble, MSN, RN
Director of Scientific Affairs & Research
CLL Society

S. Shahzad Mustafa - CLL Society

S. Shahzad Mustafa, MD
Lead Physician – Allergy, Immunology, & Rheumatology, Rochester Regional Health, Clinical Associate Professor of Medicine, University of Rochester School of Medicine and Dentistry

Find CLL Society on Social Media

Follow CLL Society on Facebook @CLLSociety as well as other social media platforms below.

This program was made possible by generous donors.

CLL Society Comments on Masking

CLL Society is proud to be an organization driven by science. We believe we have a responsibility to inform our community of the scientific information available and make recommendations in the best interest of the safety and well-being of those living with CLL. The masking study presented in this webinar comes from a well-respected and reputable scientific source, and is addressing the issue of masking’s effectiveness at the community level. CLL Society continues to support the long-recognized common medical practice of masking for individual protection.  We also continue to recommend performing an individual risk assessment and discussing your circumstances with your healthcare team.